We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Optical System Illuminates Cardiac Ablation Procedures

By HospiMedica International staff writers
Posted on 04 Jan 2016
An optical tissue characterization system for use during cardiac ablation allows cardiologists to continuously “see” into heart tissue.

The LuxCath system is intended for the treatment of all arrhythmias that require a cardiac ablation procedure, including atrial fibrillation (AF), atrial flutter, AV nodal reentrant tachycardia (AVNRT), and others. More...
The optical technology is used to directly interrogate cardiac tissue with light prior to and during ablation in order to identify tissue contact, visualize lesions, and detect lesion gaps in real-time, all without using pressure sensors or ultrasound.

The system delivers illumination and retrieves tissue fluorescence via an optical fiber with the intention of providing better tissue contact and lesion formation assessment during ablation to reduce procedure times, fluoroscopy times, arrhythmia recurrences, and costs. The LuxCath system is a product of LuxCath (Boston, MA, USA) and can be utilized as a standalone catheter or as an embedded optical technology that can be integrated into an existing ablation catheter.

“The technology identified tissue contact and was easy to use in a wide variety of settings, and we were able to assess and monitor ablation lesions as they were being created. There were no complications,” said Vivek Reddy, MD, who led the first-in-man clinical trial in 11 arrhythmia patients at Homolka Hospital (Prague, Czech Republic) conducted during December 2015. “This is an exciting step forward in the world of ablation. Based on our experience, the technology platform is quite promising.”

“We are thrilled with the performance of our optical tissue interrogation system for contact and lesion progression assessment,” said Omar Amirana, MD, CEO of LuxCath and senior vice president of its parent company, Allied Minds (Boston, MA, USA). “Given the potential to positively impact all ablation procedures, we are excited to advance the technology into the marketplace. This is an enormous milestone for the company.”

AF occurs when the heart's two upper chambers beat erratically. In one form of the condition, paroxysmal AF, patients have bouts of erratic beats that begin spontaneously and usually last less than a week. AF and other arrhythmias can lead to serious adverse events such as thrombi travelling from the heart to obstruct arteries supplying the brain, causing stroke, or thrombi in other parts of the body, causing tissue damage.

Related Links:

LuxCath
Allied Minds



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.